Niagen Bioscience Inc (NAGE): Next-Year EPS Estimate 33.49%
As of 2026-06-04, Niagen Bioscience Inc (NAGE) has a next-year EPS growth estimate of 33.49%.
On 2026-05-27, analyst consensus for NAGE's next-year EPS growth shifted from 32.61% to 33.49% — a positive change of 0.88 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at 14.60%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 33.49%
- EPS growth this year
- 14.60%
- EPS next quarter (est)
- $0.02
- Last price
- $3.50
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 33.49% | 14.60% | $0.02 | $3.50 |
| 2026-06-03 | 33.49% | 14.60% | $0.02 | $3.44 |
| 2026-06-02 | 33.49% | 14.60% | $0.02 | $3.54 |
| 2026-06-01 | 33.49% | 14.60% | $0.02 | $3.61 |
| 2026-05-31 | 33.49% | 14.60% | $0.02 | $3.86 |
| 2026-05-28 | 33.49% | 14.60% | $0.02 | $3.84 |
| 2026-05-27 | 33.49% | 14.60% | $0.02 | $3.83 |
| 2026-05-26 | 32.61% | 15.00% | $0.02 | $3.86 |
| 2026-05-25 | 32.61% | 15.00% | $0.02 | $3.66 |
| 2026-05-24 | 32.61% | 15.00% | $0.02 | $3.66 |
| 2026-05-21 | 32.61% | 15.00% | $0.02 | $3.79 |
| 2026-05-20 | 32.61% | 15.00% | $0.02 | $3.75 |
| 2026-05-19 | 32.61% | 15.00% | $0.02 | $3.67 |
| 2026-05-18 | 32.61% | 15.00% | $0.02 | $3.70 |
| 2026-05-17 | 32.61% | 15.00% | $0.02 | $3.65 |
| 2026-05-14 | 32.61% | 15.00% | $0.02 | $3.80 |
| 2026-05-13 | 32.61% | 15.00% | $0.02 | $3.82 |
| 2026-05-12 | 32.61% | 15.00% | $0.02 | $3.85 |
| 2026-05-11 | 32.61% | 15.00% | $0.02 | $3.98 |
| 2026-05-10 | 28.13% | 20.00% | $0.02 | $4.17 |
| 2026-05-07 | 28.44% | 19.94% | $0.02 | $4.19 |
| 2026-05-06 | 28.88% | 29.00% | $0.07 | $4.97 |
| 2026-05-05 | 28.88% | 29.00% | $0.07 | $4.82 |
| 2026-05-04 | 29.26% | 28.58% | $0.07 | $4.93 |
| 2026-05-03 | 28.80% | 28.30% | $0.07 | $4.85 |
| 2026-04-30 | 28.80% | 28.30% | $0.07 | $4.73 |
| 2026-04-29 | 28.80% | 28.30% | $0.07 | $4.76 |
| 2026-04-28 | 28.80% | 28.30% | $0.07 | $4.84 |
| 2026-04-27 | 28.80% | 28.30% | $0.07 | $4.96 |
| 2026-04-26 | 28.80% | 28.30% | $0.07 | $4.93 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Niagen Bioscience Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Niagen Bioscience Inc (NAGE) has a next-year EPS growth estimate of 33.49%, based on analyst consensus.
When was the latest EPS estimate revision for NAGE?▾
The most recent revision occurred on 2026-05-27, when analysts adjusted the next-year EPS growth estimate from 32.61% to 33.49%.
What sector and industry does Niagen Bioscience Inc belong to?▾
Niagen Bioscience Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NAGE appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Niagen Bioscience Inc (NAGE) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports